United Therapeutics Director Executes Stock Sale Amid Valuation and Earnings Headwinds
A director at United Therapeutics Corp (NASDAQ: UTHR), Mesa Nilda, has executed a sale of common stock totaling $150,139. The transaction, which took place on May 12, 2026, involved the disposal of 258 shares at a price point of $581.935 per share. This move occurs while the company's stock is trading in close proximity to its 52-week high of $609.…